| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d3523a7d39e7322719ce3c54947cb86 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24 |
| filingDate |
2016-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9708ade26af8b54be35a855cdb756144
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1684e6f23038220a07533eda6e0cda25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94efb9f4a4cbab808a6297549adf2924 |
| publicationDate |
2017-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2614697-C1 |
| titleOfInvention |
Neuroprotective agent |
| abstract |
FIELD: pharmacology. n SUBSTANCE: using the lithium salt of ascorbic acid is proposed to protect neurons from glutamate stress. n EFFECT: use of the invention allows to increase the effectiveness of the neurons protection from glutamate stress with reduced toxicity. n 1 tbl, 8 dwg, 2 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020005113-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2675601-C1 |
| priorityDate |
2016-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |